Skip to content

Briefing Chat: How Dolly Parton left her mark on science

Friday

About

Nature reporters discuss Dolly Parton's advocacy for vaccines and public health alongside promising phase III results for a personalised mRNA cancer vaccine for melanoma.

Topics

Related episodes

We use cookies for analytics.